RANKL Polyclonal Antibody

TNFSF11 encodes a member of the tumor necrosis factor (TNF) cytokine family which is a ligand for osteoprotegerin and functions as a key factor for osteoclast differentiation and activation. Tumor necrosis factor ligand superfamily member 11 was shown to be a dentritic cell survival factor and is involved in the regulation of T cell-dependent immune response. T cell activation was reported to induce expression of this gene and lead to an increase of osteoclastogenesis and bone loss. This protein was shown to activate antiapoptotic kinase AKT/PKB through a signaling complex involving SRC kinase and tumor necrosis factor receptor-associated factor (TRAF) 6, which indicated this protein may have a role in the regulation of cell apoptosis. Targeted disruption of the related gene in mice led to severe osteopetrosis and a lack of osteoclasts. The deficient mice exhibited defects in early differentiation of T and B lymphocytes, and failed to form lobulo-alveolar mammary structures during pregnancy. Two alternatively spliced transcript variants have been found.

The RANKL Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and quantification of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL) protein. This antibody is produced using advanced techniques to ensure high affinity and specificity, making it an ideal choice for various applications in research and diagnostics.

The RANKL Polyclonal Antibody exhibits exceptional performance in immunohistochemistry (IHC), immunofluorescence (IF), and western blotting (WB) assays. It recognizes the RANKL protein with remarkable sensitivity, enabling accurate and reliable detection even at low concentrations. This antibody demonstrates minimal cross-reactivity with other related proteins, ensuring precise and specific results.

With its superior quality and performance, the RANKL Polyclonal Antibody is an indispensable tool for studying the role of RANKL in various biological processes, including bone remodeling, immune response regulation, and cancer progression. Its versatility and reliability make it an excellent choice for researchers and clinicians seeking to unravel the intricate mechanisms underlying these complex biological phenomena.

The RANKL Polyclonal Antibody is supplied in a convenient and ready-to-use format, ensuring ease of use and saving valuable time in the laboratory. It is available in various sizes to accommodate different experimental needs. Each batch of this antibody undergoes rigorous quality control procedures to guarantee consistent and reproducible results.

In summary, the RANKL Polyclonal Antibody is a highly specific and sensitive tool that offers exceptional performance in various applications. Its reliability, versatility, and ease of use make it an invaluable asset for researchers and clinicians alike, enabling them to delve deeper into the intricate workings of RANKL and its implications in various biological processes.